Hemólisis grave por ceftriaxona
DOI:
https://doi.org/10.51987/Rev.Hosp.Ital.B.Aires.v32i1.941Resumen
.
Descargas
Referencias
Pearl RG, Sibbald WJ. Overview of ane-mia and blood management in critical care. Crit Care Med. 2003;31(12 Suppl):S649-50. DOI: https://doi.org/10.1097/00003246-200312001-00001
Harris JW. Studies on the mechanism of a drug-induced hemolytic anemia. J Lab Clin Med. 1956;47(5):760-75.
Johnson ST, Fueger JT, Gottschall JL. One center’s experience: the serology and drugs associated with drug-induced immune hemo-lytic anemia--a new paradigm. Transfusion. 2007;47(4):697-702. DOI: https://doi.org/10.1111/j.1537-2995.2007.01173.x
Packman CH. Anemia hemolítica inmune relacionada con fármacos. En: Beutler E, Li-chtman MA, Coller BS, eds., et al. Williams Hematología. Madrid: Marbán: 2007. Sec. V, Cap. 57, p. 503-8.
Garratty G. Immune cytopenia associ-ated with antibiotics. Transfus Med Rev. 1993;7(4):255-67. DOI: https://doi.org/10.1016/S0887-7963(93)70145-5
Seltsam A, Salama A. Ceftriaxone-induced immune haemolysis: two case reports and a concise review of the literature. Intensive Care Med. 2000;26(9):1390-4. DOI: https://doi.org/10.1007/s001340000598
Shulman IA, Arndt PA, McGehee W, et al. Cefotaxime-induced immune hemolytic anemia due to antibodies reacting in vitro by more than one mechanism. Transfusion. 1990;30(3):263-6. DOI: https://doi.org/10.1046/j.1537-2995.1990.30390194351.x
Mandell GL, Sande MA. Antimicrobial agents: penicillins, cephalosporins, and other beta-lactam antibiotics. En: Goodman Gilman A, Rall TW, Nies AS, eds., et al. Goodman and Gilman’s the pharmacological basis of thera-peutics. 8th ed. New York: Pergamon Press; 1990. Sec. XI, Cap. 46, p. 1065-97.
Quagliarello VJ, Scheld WM. Treat-ment of bacterial meningitis. N Engl J Med. 1997;336(10):708-16. DOI: https://doi.org/10.1056/NEJM199703063361007
Odio CM, Faingezicht I, Paris M, et al. The beneficial effects of early dexametha-sone administration in infants and children with bacterial meningitis. N Engl J Med. 1991;324(22):1525-31. DOI: https://doi.org/10.1056/NEJM199105303242201
Stankievich E, García Arrigoni P, Rodrí-guez de Schiavi S. Crisis hemolítica no fatal asociada a ceftriaxone en un niño con SIDA. Arch Argent Pediatr. 2001;99(1):49-51.
Mandell GL, Sande MA. Antimicrobial agents: penicillins, cephalosporins, and other beta-lactam antibiotics. Op cit.
Garratty G, Postoway N, Schwellenbach J, et al. A fatal case of ceftriaxone (Rocephin)-induced hemolytic anemia associated with intravascular immune hemolysis. Transfusion. 1991;31(2):176-9 DOI: https://doi.org/10.1046/j.1537-2995.1991.31291142951.x
Lascari AD, Amyot K. Fatal hemolysis caused by ceftriaxone. J Pediatr. 1995;126(5 Pt 1):816-7. DOI: https://doi.org/10.1016/S0022-3476(95)70418-3
Meyer O, Hackstein H, Hoppe B, Göbel FJ, Bein G, Salama A. Fatal immune haemol-ysis due to a degradation product of ceftriax-one. Br J Haematol. 1999;105(4):1084-5. DOI: https://doi.org/10.1046/j.1365-2141.1999.01434.x
Borgna-Pignatti C, Bezzi TM, Reverberi R. Fatal ceftriaxone-induced hemolysis in a child with acquired immunodeficiency syndrome. Pediatr Infect Dis J. 1995;14(12):1116-7. DOI: https://doi.org/10.1097/00006454-199512000-00023
Ye W, Liu CW. A case of ceftriaxone-induced haemolysis complicated by acute portal vein thrombosis. Chin Med J (Engl). 2011;124(1):152-4.
Dinesh D, Dugan N, Carter J. Intravascu-lar haemolysis in a patient on ceftriaxone with demonstration of anticeftriaxone antibodies. Intern Med J. 2008;38(6):438-41. DOI: https://doi.org/10.1111/j.1445-5994.2008.01656.x
Bernini JC, Mustafa MM, Sutor LJ, Bu-chanan GR. Fatal hemolysis induced by cef-triaxone in a child with sickle cell anemia. J Pediatr. 1995;126(5 Pt 1):813-5 DOI: https://doi.org/10.1016/S0022-3476(95)70417-5
Descargas
Compartir artículo
Publicado
Número
Sección
Licencia
Derechos de autor 2012 Revista del Hospital Italiano de Buenos Aires
Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial-CompartirIgual 4.0.
